Effect of Vitamin D Supplementation on COVID-19 Patients: A Systematic Review and Meta-analysis

Overview

Journal Front Nutr

Specialty Nutritional Sciences

Date 2023 Mar 24

PMID 36960206

Authors

Ying Zhang

Jing Li

Min Yang

Qin Wang

Affiliations

Soon will be listed here.

Abstract

Objective: To systematically evaluate the impact of vitamin D supplementation on mortality, ICU admission, and the rates of mechanical ventilation or intubation among COVID-19 patients.

Data Sources And Study Selection: The PubMed, Embase, Cochrane Library, CBM, CNKI, VIP, and WanFang databases were searched from 1 December 2019 to 31 December 2022. The authors sought to identify randomized controlled trials and cohort studies that examined the relationship between vitamin D supplementation and mortality, ICU admission, and mechanical ventilation or intubation rates among COVID-19 patients.

Data Extraction And Synthesis: Two investigators independently searched the literature, extracted the data, and assessed the quality of the included studies. The Grading of Recommendation, Assessment, Development, and Evaluation approach was used to evaluate the quality of the evidence. Meta-analysis was conducted using RevMan 5.3, STATA 15.1, and R 4.1.3 software.

Results: Eight randomized controlled trials (RCTs) and eight cohort studies were included, involving 3359 COVID-19 patients. The pooled analysis of randomized controlled trials showed that vitamin D supplementation did not have a significant effect on reducing mortality (Relative Risk, RR = 0.94, 95% CI 0.69-1.29, = 0.7), while the results of cohort studies indicated that vitamin D supplementation had a positive impact on reducing mortality among COVID-19 patients (RR = 0.33, 95% CI 0.23-0.47, < 0.001). There was no statistically significant difference in the rates of ICU admission (RCTs: RR = 0.64, 95%CI 0.38-1.08, = 0.10; cohort studies: RR = 0.32, 95% CI 0.08-1.29, = 0.109) or rates of mechanical ventilation or intubation (RCTs: RR = 0.77, 95% CI 0.58-1.02, = 0.07; cohort studies: RR = 0.93, 95% CI 0.55-1.58, = 0.789).

Conclusion: The results of this systematic review and meta-analysis suggest that vitamin D supplementation does not have a significant impact on reducing mortality, ICU admission, and the rates of mechanical ventilation or intubation among COVID-19 patients. However, due to the limited number and quality of the studies included, further high-quality studies are needed to confirm these findings.

Systematic Review Registration: www.crd.york.ac.uk, identifier CRD42021299521.

Citing Articles

Vitamin D supplementations and mortality among patients with moderate/severe COVID-19: A meta-analysis of randomized controlled trials.

Mirghani H, Begum S J Res Med Sci. 2025; 29:68.

PMID: 39764224 PMC: 11702351. DOI: 10.4103/jrms.jrms_591_23.

The Efficacy of Multivitamin, Vitamin A, Vitamin B, Vitamin C, and Vitamin D Supplements in the Prevention and Management of COVID-19 and Long-COVID: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Sinopoli A, Sciurti A, Isonne C, Santoro M, Baccolini V Nutrients. 2024; 16(9).

PMID: 38732592 PMC: 11085542. DOI: 10.3390/nu16091345.

High-dose vitamin D supplementation in patients with COVID-19: A meta-analysis of randomized controlled trials.

Zhong Z, Zhao L, Zhao Y, Xia S Food Sci Nutr. 2024; 12(3):1808-1817.

PMID: 38455212 PMC: 10916595. DOI: 10.1002/fsn3.3875.

Dietary Vitamin D Mitigates Coronavirus-Induced Lung Inflammation and Damage in Mice.

Campolina-Silva G, Dos Santos Pereira Andrade A, Couto M, Bittencourt-Silva P, Queiroz-Junior C, Lacerda L Viruses. 2023; 15(12).

PMID: 38140675 PMC: 10748145. DOI: 10.3390/v15122434.

Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy.

Gomaa A, Abdel-Wadood Y, Thabet R, Gomaa G Inflammopharmacology. 2023; 32(1):249-271.

PMID: 37957515 PMC: 10907442. DOI: 10.1007/s10787-023-01383-x.

References

Hernandez J, Nan D, Fernandez-Ayala M, Garcia-Unzueta M, Hernandez-Hernandez M, Lopez-Hoyos M . Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection. J Clin Endocrinol Metab. 2021; 106(3):e1343-e1353. DOI: 10.1210/clinem/dgaa733. View

Li B, Yang S, Hou N . Could vitamin D supplementation play a role against COVID-19?. Front Immunol. 2022; 13:967215. PMC: 9511139. DOI: 10.3389/fimmu.2022.967215. View

DEcclesiis O, Gavioli C, Martinoli C, Raimondi S, Chiocca S, Miccolo C . Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis. PLoS One. 2022; 17(7):e0268396. PMC: 9258852. DOI: 10.1371/journal.pone.0268396. View

Rawat D, Roy A, Maitra S, Shankar V, Khanna P, Baidya D . "Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis". Diabetes Metab Syndr. 2021; 15(4):102189. PMC: 8236412. DOI: 10.1016/j.dsx.2021.102189. View

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. PMC: 3196245. DOI: 10.1136/bmj.d5928. View

Shah K, Saxena D, Mavalankar D . Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis. QJM. 2021; 114(3):175-181. PMC: 7928587. DOI: 10.1093/qjmed/hcab009. View

Elamir Y, Amir H, Lim S, Rana Y, Lopez C, Viera Feliciano N . A randomized pilot study using calcitriol in hospitalized COVID-19 patients. Bone. 2021; 154:116175. PMC: 8425676. DOI: 10.1016/j.bone.2021.116175. View

Benskin L . A Basic Review of the Preliminary Evidence That COVID-19 Risk and Severity Is Increased in Vitamin D Deficiency. Front Public Health. 2020; 8:513. PMC: 7513835. DOI: 10.3389/fpubh.2020.00513. View

10.

Rhodes J, Dunstan F, Laird E, Subramanian S, Kenny R . COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D. BMJ Nutr Prev Health. 2020; 3(1):118-120. PMC: 7664496. DOI: 10.1136/bmjnph-2020-000110. View

11.

Nogues X, Ovejero D, Pineda-Moncusi M, Bouillon R, Arenas D, Pascual J . Calcifediol Treatment and COVID-19-Related Outcomes. J Clin Endocrinol Metab. 2021; 106(10):e4017-e4027. PMC: 8344647. DOI: 10.1210/clinem/dgab405. View

12.

Guyatt G, Oxman A, Kunz R, Woodcock J, Brozek J, Helfand M . GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol. 2011; 64(12):1294-302. DOI: 10.1016/j.jclinepi.2011.03.017. View

13.

Annweiler C, Beaudenon M, Simon R, Guenet M, Otekpo M, Celarier T . Vitamin D supplementation prior to or during COVID-19 associated with better 3-month survival in geriatric patients: Extension phase of the GERIA-COVID study. J Steroid Biochem Mol Biol. 2021; 213:105958. PMC: 8319044. DOI: 10.1016/j.jsbmb.2021.105958. View

14.

Gibbons J, Norton E, McCullough J, Meltzer D, Lavigne J, Fiedler V . Association between vitamin D supplementation and COVID-19 infection and mortality. Sci Rep. 2022; 12(1):19397. PMC: 9653496. DOI: 10.1038/s41598-022-24053-4. View

15.

Guven M, Gultekin H . The effect of high-dose parenteral vitamin D on COVID-19-related inhospital mortality in critical COVID-19 patients during intensive care unit admission: an observational cohort study. Eur J Clin Nutr. 2021; 75(9):1383-1388. PMC: 8299443. DOI: 10.1038/s41430-021-00984-5. View

16.

Zurita-Cruz J, Fonseca-Tenorio J, Villasis-Keever M, Lopez-Alarcon M, Parra-Ortega I, Lopez-Martinez B . Efficacy and safety of vitamin D supplementation in hospitalized COVID-19 pediatric patients: A randomized controlled trial. Front Pediatr. 2022; 10:943529. PMC: 9357919. DOI: 10.3389/fped.2022.943529. View

17.

Wen W, Chen C, Tang J, Wang C, Zhou M, Cheng Y . Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis. Ann Med. 2022; 54(1):516-523. PMC: 8820829. DOI: 10.1080/07853890.2022.2034936. View

18.

Jevalikar G, Mithal A, Singh A, Sharma R, Farooqui K, Mahendru S . Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19. Sci Rep. 2021; 11(1):6258. PMC: 7973709. DOI: 10.1038/s41598-021-85809-y. View

19.

De Niet S, Tremege M, Coffiner M, Rousseau A, Calmes D, Frix A . Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2022; 14(15). PMC: 9330587. DOI: 10.3390/nu14153048. View

20.

Sterne J, Hernan M, Reeves B, Savovic J, Berkman N, Viswanathan M . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016; 355:i4919. PMC: 5062054. DOI: 10.1136/bmj.i4919. View